Orexins and Emerging Indications for Use in Psychiatry Beyond Insomnia

Speaker

Roger W. Sommi, Pharm.D., BCPP, FCCP

Professor Emeritus of Pharmacy Practice and Psychiatry

Division of Pharmacy Practice and Administration

UMKC School of Pharmacy

Learning Objectives

Discuss the physiologic function and distribution of excitatory neuropeptides orexin/hypocretin.
Review the orexin mechanism of currently FDA-approved agents targeting orexin/hypocretin.
Outline current research and possible future targets for these neuropeptides and their receptors, including addiction, inflammation, Alzheimer's disease, obesity and depression.

Instructions

This program consists of one video and downloadable resources in PDF format.

To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date.

Speaker information and disclosures can be found in the tab below.

Fee

$20.00

CE Hours

1.00

CE Units

0.100

Support/Credits

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. To receive 1.00 contact hour of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).

Orexins and Emerging Indications for Use in Psychiatry Beyond Insomnia

About the Speaker

Roger W. Sommi, Pharm.D., BCPP, FCCP

Professor Emeritus of Pharmacy Practice and Psychiatry

Division of Pharmacy Practice and Administration

UMKC School of Pharmacy

Dr. Sommi is Professor Emeritus at the UMKC School of Pharmacy - Department of Pharmacy Practice, with a cross-appointment in the Department of Psychiatry in the UMKC School of Medicine and is a Pharmacy Consultant for the Missouri Department of Mental Health. He received his BS in Pharmacy from the University of Wisconsin at Madison, Doctor of Pharmacy from the University of Utah, Residency in Hospital Pharmacy at the University of Utah Hospital and Fellowship in Psychopharmacy at the University of Texas at Austin. He is board-certified in Psychiatric Pharmacy Practice by the Board of Pharmaceutical Specialties and is a Fellow of the American College of Clinical Pharmacy.

Throughout his career, Dr. Sommi has been a preceptor, served as Associate Dean, been a research director, served as a founding member, Past President, and on various committees of the College of Psychiatric and Neurologic Pharmacists. He was actively involved in the establishment of Psychiatric Pharmacy as a specialty and worked to develop the recertification process for psychiatric pharmacy. Currently, he is involved with the regional Crisis Intervention Team training program in the Kansas City area and is a member of ACCP, AACP, APhA, Missouri Pharmacists Association, and the Missouri, Greater Kansas City and Mid-Missouri Society of Health-System Pharmacists.

Dr. Sommi’s area of research interest is primarily in outcomes associated with drug treatment of schizophrenia and other psychiatric disorders.

Disclosure: Dr. Roger Sommi has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

- - Role: Presenter
  - Companies: Karuna, Alkermes, Boeringer Ingelheim, TEA
  - Affiliation: Speaker, advisory board, research support

Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.

Activity Number

0067-0000-23-161-H01-P/T

Release Date: Oct 26, 2023

Credit Expiration Date: Oct 25, 2026

CE Hours

1.00